Evolving Treatments: A Review of What’s in the Pipeline

Host: Alan S. Brown, MD, FACC, FAHA, FNLA

Guest: Harold Bays, MD, FNLA

Host Dr. Alan Brown and guest, Dr. Harold Bays discuss the evolving treatments in lipid management and what we will be expecting in the future. They will address the role of niacin, the status of laropiprant, an overview of fish oils and omega-3 fatty acids and the novel approaches being used in today's research of lipid-altering drugs. Harold E. Bays MD, FACP, FACE, FNLA is the Medical Director and President of the Louisville Metabolic and Atherosclerosis Research Center Inc. (L-MARC) in Louisville, KY. And, has served as an Investigator in over 400 Phase I - IV clinical trials for treatments for high cholesterol and other dyslipidemias, obesity, diabetes mellitus, hypertension, osteoporosis, and other metabolic and hormonal disorders. Dr. Bays has also served as Medical Director of L-MARC Research Center since 1989 - a clinical research facility originally established in 1989 - and President of L-MARC Research Center since its independent incorporation in 1998.